FDA Approves New Warnings to All Testosterone Product Labels
The U.S. Food and Drug Administration (FDA) approved new labeling changes for all prescription testosterone products. Labels will now include a new Warning, as well as updated language in the Abuse and Dependence section to alert prescribers to the abuse potential of testosterone and the risks associated with testosterone and anabolic androgenic steroid (AAS) abuse and dependence. Learn more about the FDA announcement.
Read the AUA position statement on Testosterone Therapy, which highlights the risks associated with the misuse of testosterone for non-medical indications.